AerWave Completes First-in-Human Study to Advance Disease …
2 days ago · - Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions ...
AerWave Medical concludes study of ultrasound therapy for COPD
21 hours ago · AerWave Medical has concluded the feasibility study of its ultrasound lung denervation therapy, designed to treat chronic obstructive pulmonary disease (COPD) and asthma. The first-in-human study ...
Aerwave’s Ultrasound Therapy Shows Promise for COPD & Asthma
1 day ago · AerWave Medical completed its first-in-human feasibility study of a novel ultrasound lung denervation therapy for chronic obstructive pulmonary disease (COPD) and asthma. The study, involving five patients, confirmed the feasibility and efficiency of AerWave’s ultrasound platform, which simplifies lung denervation by eliminating the need for fluoroscopic guidance, esophageal marker balloons ...
AerWave Completes First-in-Human Study to Advance
2 days ago · AerWave Medical is a medical device company pioneering ultrasound-based therapies for respiratory diseases. With its advanced therapeutic platform, AerWave is transforming the landscape of ...
Aerwave in the News and Press: Stay Updated with the Latest - Aerwave …
Stay informed with the latest Aerwave news and press releases. Get all the updates and insights from Team Aerwave and about managed Wi-Fi.
Lucius Partners Portfolio Company AerWave Medical, Inc.
Aug 22, 2024 · Lucius Partners, LLC ("LP") today announced that its portfolio company, AerWave Medical, Inc., has completed treatment of its first three patients in its First-in-Human Trial (FIH) conducted at...
News - Aerwave
Mar 29, 2023 · Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Has Filed Two New Patent Applications Further Advances IP Portfolio Address Key Issues in Treatment of COPD & Asthma NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Lucius Partners, LLC (“LP”), today announced the filing [...]
Lucius Partners Portfolio Company AerWave Medical, Inc ... - BioSpace
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Lucius Partners, LLC (“LP”) today announced that its portfolio company, AerWave Medical, Inc., has completed treatment of its first three patients in its First-in-Human Trial (FIH) conducted at Healthycore in Tbilisi, Georgia.
Press Room - Aerwave
Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Initiated Filing of Regulatory Documents for First in Man Studies
AerWave Completes First-in-Human Study to Advance Disease …
2 days ago · /EIN News/ -- - Company has also raised $12 million in funding led by Lucius Partners. NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional ...
- Some results have been removed